SS Innovations’ robot won approvals to perform telesurgery in Indonesia and the Philippines, while the first remote robotic mechanical thrombectomy to treat stroke was performed with XCath’s system.
SS Innovations ramps up in telesurgery; XCath robot treats stroke remotely Read More »
The new agreement will give Humana’s MA members access to CommonSpirit’s doctors and facilities for the next three years, and returns CommonSpirit to Humana’s networks in Colorado and Texas.
CommonSpirit, Humana reach new nationwide Medicare Advantage contract Read More »
The 510(k) decision clears the company to challenge Siemens Healthineers for an emerging part of the CT imaging sector.
GE HealthCare wins FDA nod for photon-counting CT technology Read More »
Draft guidance, issued by the FDA last week, could remove ambiguity and uncertainty that may have so far limited uptake of new approach methodologies, experts told BioSpace, particularly emphasizing the agency’s recommendations around defining NAMs’ regulatory purpose.
FDA Blueprint Aims To Cut Regulatory Risk for Alternatives to Animal Testing Read More »
El interés por mejorar el rendimiento físico y alcanzar una musculatura definida ha crecido notablemente en los últimos años. Muchas personas buscan alternativas que les ayuden a lograr sus objetivos de forma más rápida y eficiente, recurriendo a diversas es …
Factores a considerar antes de utilizar suplementos para el rendimiento Read More »
La terapia post ciclo es un componente crucial para aquellos que han completado un ciclo de esteroides anabólicos. Sin embargo, muchas personas no están completamente informadas sobre su importancia y el impacto que puede tener en el cuerpo. Para aquellos interesados en conocer m&aacut …
Merit’s basivertebral nerve ablation system is expected to round out Medtronic’s pain treatment options.
Medtronic to distribute Merit Medical’s low back pain treatment Read More »
Aardvark Therapeutics’ obesity asset is based on its lead molecule, which in February was linked to reversible heart safety signals in a healthy volunteer study.
Aardvark Pauses 2 Obesity Trials, Reveals New Details on Cardiac Concerns Read More »
Like its pharma peers, Novartis is pouring money into Chinese operations, including expansions and upgrades at an existing manufacturing facility.
Novartis Pledges $480M To Expand China Presence, Following Eli Lilly and AstraZeneca Read More »
Following last month’s $7.8 billion purchase of CAR T biotech Arcellx, Gilead’s dealmaking train chugs along with yet another acquisition—this time securing Ouro Medicines’ pipeline of T cell engagers for inflammatory diseases.
Gilead Drops $2.1B for Ouro, Hopes To Split Cost with Galapagos Read More »
